Terapias biológicas en el tratamiento de Psoriasis

Pathway Analysis of Skin from Psoriasis Patients after Adalimumab Treatment Reveals New Early Events in the Anti-Inflammatory Mechanism of Anti-TNF-α.
Psoriasis is a chronic cutaneous inflammatory disease. The immunopathogenesis is a com-plex interplay between T cells, dendritic cells and the epidermis in which T cells and dendritic cells maintain  skin inflammation. Anti-tumour necrosis factor (anti-TNF)-α agents have been approved for therapeutic use across a range of inflammatory disorders including psoriasis, but the anti-inflammatory mechanisms of anti-TNF-α in lesional psoriatic skin are not fully understood. We investigated early events in skin from psoriasis patients after treatment with anti-TNF-α antibodies by use of bioinformatic s tools.

Comentarios: Haga un comentario

08/07/2021

tania @ 4:57 pm #

Muy interesante el tema. ¿Cómo se comporta en Cuba?

Haga un comentario

Los campos marcados con asterisco (*) son obligatorios.

*